Five Innovative Medical Devices Enter NMPA Fast-Track Review Program

Apr 01, 2026 18:09 CST Updated 18:09

Zylox-Tonbridge

Innovative R&D, Production, and Sales of Medical Devices in the Vascular Intervention Field

WYTD

Developer of Cardiac Disease Diagnosis and Treatment Equipment

V-Onco

Irreversible Electroporation Technology Developer

ANGELAIGN

Dental Medical Consumables Supplier and Service Provider

Neusoft

Comprehensive Solution Provider for Clinical Diagnosis and Treatment

Instrument Family

Pioneer in Medical Device Media Reports

Share Professional Medical Device Knowledge

Source:Center for Medical Device Evaluation, National Medical Products Administration

The following is the main text:

NMPA CMDE has just released, full text as follows:

According to the "Special Review Procedure for Innovative Medical Devices" (Announcement No. 83 of 2018 by the National Medical Products Administration), the Office for the Review of Innovative Medical Devices has organized relevant experts to review applications for special review. The following application projects are proposed to be approved to enter the special review procedure and are now being publicized. The public announcement period is from April 1, 2026, to April 16, 2026.

1. Product Name: Peripheral Dot Stent System

Applicant: Zylox-Tonbridge Medical Technology Co.,Ltd.

2. Product Name: Ceramic Dental Implant System

Applicant: Beijing Ruici Medical Technology Co., Ltd.

3. Product Name: Patent Foramen Ovale (PFO) Closure Device

Applicant: WYTD MEDICAL TECHNOLOGY (SHENZHEN) CO., LTD.

4. Product Name: Steep Pulse Treatment Device

Applicant: Hangzhou V-Onco Medical Technology Co., Ltd.

5. Product Name: Toric Posterior Chamber Phakic Intraocular Lens

Applicant: Wuxi Carl Zeiss Reming Opto-Medical Technology Co., Ltd.

END